Mirivadelgat
Group 3 Pulmonary Hypertension
Phase II
Recruiting
Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD (Windward)
Jun 12, 2024
―
Leuprolide Mesylate, Subcutaneous Injection Of 42 Mg Leuprolide
Puberty; Precocious, Central
Phase III
Completed
Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty
Aug 04, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does QPS Holdings, Inc. (464A) have in its pipeline
464A is currently developing the following drugs: Linvemastat, Mirivadelgat, Leuprolide Mesylate, Subcutaneous Injection Of 42 Mg Leuprolide. These drug candidates are in various stages of clinical development as the company works toward FDA approval.